No Data
No Data
Morgan Stanley Initiates ROHTO PHARMACEUTICAL CO(RPHCF.US) With Buy Rating, Announces Target Price $27.98
J.P. Morgan Maintains ROHTO PHARMACEUTICAL CO(RPHCF.US) With Buy Rating, Cuts Target Price to $24
Nomura Maintains ROHTO PHARMACEUTICAL CO(RPHCF.US) With Buy Rating, Cuts Target Price to $24.68
Jefferies Initiates ROHTO PHARMACEUTICAL CO(RPHCF.US) With Sell Rating, Announces Target Price $15.8
Nomura Initiates ROHTO PHARMACEUTICAL CO(RPHCF.US) With Buy Rating, Announces Target Price $32.53
Nomura analyst Kyoichiro Shigemura initiates coverage on $ROHTO PHARMACEUTICAL CO(RPHCF.US)$ with a buy rating, and sets the target price at $32.94.According to TipRanks data, the analyst has a
ROHTO PHARMACEUTICAL CO To Go Ex-Dividend On September 27th, 2024 With 0.1408 USD Dividend Per Share
July 9th (Eastern Time) - $ROHTO PHARMACEUTICAL CO(RPHCF.US)$ is trading ex-dividend on September 27th, 2024.Shareholders of record on September 30th, 2024 will receive 0.132 USD dividend per share